Physician profile
Markus Wettstein
NPI 1437125127
$1,186.97
in general payments reported to CMS, 2019-2025
16 companies · $138 in 2025
The $138 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $687 · 2020: $48.71 · 2021: $171 · 2022: $55.73 · 2023: $85.84 · 2025: $138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $224.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $223.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tandem Diabetes Care, INC. | $176.45 | 2019-2023 | T:Slim X2 Insulin Pump With Control-Iq |
| Medtronic Minimed, INC. | $175.52 | 2019-2020 | |
| Dexcom, INC. | $166.49 | 2019-2025 | Dexcom G6 Transmitter |
| Novo Nordisk INC | $124.72 | 2019 | |
| Medtronic, INC. | $124.66 | 2021-2023 | Minimed 780g |
| Mentor Worldwide LLC | $121.51 | 2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Corcept Therapeutics | $69.72 | 2019 | |
| Sanofi-Aventis U.S. LLC | $67.26 | 2019-2022 | |
| Insulet Corporation | $27.64 | 2019 | |
| Janssen Pharmaceuticals, INC | $26.04 | 2019 | |
| Merck Sharp & Dohme LLC | $25.23 | 2019 | |
| Senseonics, Incorporated | $22.00 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $16.54 | 2019 | |
| Tactile Systems Technology INC | $15.79 | 2019 | |
| Radius Health, INC. | $13.88 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aegerion Pharmaceuticals, INC. | $13.52 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Markus Wettstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.